Joined April 2020
Photos and videos
Pinned Tweet
My owner has palliated me, DNACPR completed, I have sent my last tweet. Thank you for your interest while it lasted. 2020 - 2022
1
OneLineSummary Bot retweeted
My owner has palliated me, DNACPR completed, I have sent my last tweet. Thank you for your interest while it lasted. 2020 - 2022
1
Adhikari - 2007 - Metanalysis of 12 trials of iNO in ARDS - ∅mortality, ↑pO2, AKI, metHb, ICH in children - ncbi.nlm.nih.gov/pubmed/1738…

Daeppen - 2002 - Symptom based CIWA-Ar benzodiazepine vs fixed dose in alcohol withdrawal - ↓ hospital LOS, total benzodiazepine dose - ncbi.nlm.nih.gov/pubmed/1202… #CIWAAr

SELECT-D - 2018 - Rivaroxaban vs dalteparin in cancer-related VTE - ↓recurrent VTE, ↑non-major bleeding - ncbi.nlm.nih.gov/pubmed/2974…

TTM - 2013 - 33 vs 36oC after CA - ∅mortality or neurological outcome - ncbi.nlm.nih.gov/pubmed/2423…

TRACMAN - 2013 - Early D4 vs Late >D10 tracheostomy - ∅mortality, LOS ↑complications in late group - ncbi.nlm.nih.gov/pubmed/2369… #D4vsLateD10

Villanueva - 2013 - Restrictive transfusion >70 vs liberal >90 in UGIB - ↓mortality, further bleeding, total RBCs - ncbi.nlm.nih.gov/pubmed/2328…

STOPAH - 2015 - Prednisolone vs pentoxyphyllin vs placebo in alcoholic hepatitis - ∅28d, 90d or 1y mortality - ncbi.nlm.nih.gov/pubmed/2590…

Blum - 2015 - Prednisone vs conventional therapy for CAP - ↓time to stability, LOS, ABx duration, ∅mortality - ncbi.nlm.nih.gov/pubmed/2560…

BALTI-2 - 2012 - IV salbutamol vs placebo in ARDS - ↑mortality - ncbi.nlm.nih.gov/pubmed/2216…

V-HeFT - 1986 - ISDN/hydralazine vs prazosin vs placebo in DCM and LVF - ∅mortality or LVEF - ncbi.nlm.nih.gov/pubmed/3520…

OSCILLATE - 2013 - HFOV vs IPPS in mod-sev early ARDS - ↑mortality, sedation, NMBD, vasopressors - ncbi.nlm.nih.gov/pubmed/2333…

DECREASE-IV - 2009 - Bisoprolol vs pravastatin vs control in perioperative non-cardiac patients - ↓30d MI/death with bisoprolol - ncbi.nlm.nih.gov/pubmed/1947…

Bernard - 2002 - Therapeutic hypothermia vs normothermia in OOH VF arrest - ↑ favourable neurological outcome - ncbi.nlm.nih.gov/pubmed/1185…

EVEREST - 2007 - Tolvaptan vs placebo in HFrEF - ∅ all-cause mortality, CV mortality, rehospitalisation - ncbi.nlm.nih.gov/pubmed/1738…

RENAL - 2009 - CVVHDF 40ml/kg/hr vs 25ml/kg/hr - ∅28d mortality, RRT dependence, days on RRT, LOS, duration IPPV, SOFA score - ncbi.nlm.nih.gov/pubmed/1984…

PROTECT-AF - 2009 - LAA closure vs warfarin in non-valvular AF - closure non-inferior to warfarin - ncbi.nlm.nih.gov/pubmed/1968…

CARES - 2018 - Febuxostat vs allopurinol in gout with co-morbid CVD - ↑ all cause and CV death, ∅ non-fatal CV events - ncbi.nlm.nih.gov/pubmed/2952…